Study guide

3.6 Patient Counseling & Patient-Centered Labeling

California Practice Standards and Jurisprudence Examination for Pharmacists CPJE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Patient Information & Prescription Evaluation (Domain 1)

1.1 Patient Profile & Health Data Acquisition 1.2 Prescription Authenticity & Prescriber Authority 1.3 California Security Prescription Forms & E-Prescribing Mandates (B&P § 688) 1.4 Clinical Evaluation of Dosing & Organ Impairment 1.5 Drug-Drug & CYP450 Interactions 1.6 Special Populations & High-Risk Medications 1.7 Physical Assessment & Health Screening 1.8 Final Check, Labeling Verification & Product Selection Workflow

2 Chapter 2: Clinical Practice & Disease State Management (Domain 2: Clinical Practice & Jurisprudence)

2.1 Cardiovascular Therapeutics & Clinical Law 2.2 Endocrine & Metabolic Disorders 2.3 Respiratory & Infectious Disease Management 2.4 Central Nervous System & Pain Management 2.5 Oncology, Immunology & Specialty Pharmacy 2.6 Medication Therapy Management & Collaborative Goals of Therapy 2.7 Formulary Systems, Therapeutic Interchange & Medication Affordability 2.8 Medication Reconciliation & Ordering Monitoring Procedures

3 Chapter 3: California Pharmacy Jurisprudence & Prescriptive Authority (Domain 2: Clinical Practice & Jurisprudence)

3.1 Controlled Substances & CURES PDMP 3.2 Controlled Substance Dispensing, Refills, & Partial Fills 3.3 Independent Pharmacist Furnishing Scope 3.4 Advanced Pharmacist Practitioner (APP/APh) & CDTM 3.5 Immunization Authority & CAIR Reporting 3.6 Patient Counseling & Patient-Centered Labeling 2.9 OTC, CAM, Lifestyle Counseling & Teach-Back 2.10 Educating Health Professionals & Supplemental Patient Information

4 Chapter 4: Pharmacy Operations, Board Governance & Personnel (Domain 3: Pharmacy Operations & Jurisprudence)

California Board of Pharmacy Governance & Licensure Pharmacist Continuing Education & License Maintenance Pharmacist-in-Charge (PIC) & Pharmacy Ownership Pharmacy Personnel & Supervision Ratios Pharmacy Security, Theft, & Diversion Reporting 4.6 Controlled Substance Inventory & Record Reconciliation 4.7 Quality Assurance, Medication Error Systems & ADR Reporting 4.8 Privacy, Confidentiality & Pharmacy Policies and Procedures

5 Chapter 5: Drug Supply Chain, Dispensing & Compounding Regulations (Domain 3: Pharmacy Operations & Jurisprudence)

5.1 Drug Procurement, DSCSA Track & Trace, & Storage 5.2 Generic Substitution, Bioequivalence, & Orange Book 5.3 Prescription Transfer, Refills, & Off-Site Dispensing 5.4 Non-Sterile Compounding Standards 5.5 Sterile Compounding & Hazardous Drug Handling 5.6 Emergency Preparedness & Continuity of Pharmacy Operations

3.6 Patient Counseling & Patient-Centered Labeling

Key Takeaways Explain This Topic AI

Pharmacists have a strict duty to provide an oral consultation for all new prescriptions and changes in dosage, form, or strength (16 CCR § 1707.2).

The offer to counsel must be made by the pharmacist, not a clerk or technician.

Patient-centered labels must dedicate at least 50% of the label to primary information in 12-point sans-serif font (16 CCR § 1707.5).

Pharmacies must provide translated directions for use in multiple languages upon request.

Last updated: July 2026

The Duty to Consult (16 CCR § 1707.2)

Patient counseling is one of the most critical clinical functions a pharmacist performs. In California, the Board of Pharmacy places immense emphasis on the "duty to consult." Under 16 California Code of Regulations (CCR) § 1707.2, a pharmacist must provide an oral consultation to the patient or the patient's agent in specific circumstances.

Mandatory Consultation Triggers: A pharmacist must provide an oral consultation in the following scenarios:

Whenever a prescription drug has not been previously dispensed to the patient.

Whenever a prescription drug is dispensed in a different dosage form, strength, or with a new written direction (e.g., a change from taking a medication once a day to twice a day).

Upon the patient's request.

Whenever the pharmacist, in their professional judgment, deems a consultation necessary to prevent harm or ensure optimal therapy.

Content of the Consultation: The mandatory oral consultation must include, at a minimum, the following clinical elements:

Directions for use and storage and the importance of compliance with directions.

Precautions and relevant warnings, including common and severe side effects or adverse effects, and drug interactions.

Who Makes the Offer? Crucially, California law prohibits a pharmacy clerk, cashier, or technician from asking the patient if they have questions or if they want to decline counseling (e.g., a cashier cannot say, "Do you have any questions for the pharmacist?"). The pharmacist must be the one to engage the patient. If the prescription requires consultation, the staff must inform the patient that "the pharmacist would like to speak with you" or simply direct the patient to the counseling window. Only the patient or their agent can refuse the consultation, and this refusal must be documented.

If the medication is mailed or delivered, the pharmacy must include a written notice of the patient's right to request a consultation and provide a toll-free telephone number where a pharmacist is available during regular business hours for at least 6 days a week, and for a minimum of 40 hours a week.

Patient-Centered Prescription Labeling (16 CCR § 1707.5)

To reduce medication errors and improve patient comprehension, California instituted strict requirements for "patient-centered" prescription labels under 16 CCR § 1707.5. These requirements ensure that the most critical information on a prescription bottle is prominent and easy to read, particularly for elderly patients or those with visual impairments.

Label Formatting Requirements: The label must be formatted such that at least 50% of the prescription label is dedicated to the "primary" information. This 50% area must be uncluttered and distinct from the pharmacy logo, barcode, or auxiliary warnings. The text in this primary area must be printed in at least a 12-point sans-serif typeface (e.g., Arial, Calibri, Helvetica).

The Primary Information: The primary information that must occupy this 50% space includes:

The patient's name.

The drug name and strength (the generic name must be listed; if a brand is dispensed, the generic must say "generic for [Brand]").

The directions for the use of the drug.

The condition or purpose for which the drug was prescribed, if indicated on the prescription.

Translation Services: California is a linguistically diverse state, and language barriers significantly contribute to medication non-adherence and errors. The Board requires pharmacies to provide translated directions for use upon a patient's request. The Board provides standardized translated directions in multiple languages (such as Spanish, Chinese, Vietnamese, Korean, and Russian) on its website. If a patient requests a translated label in one of these supported languages, the pharmacy must print the translated directions on the prescription container label. If the translated directions do not fit on the primary label, they can be printed on a supplemental label attached to the container. An English version of the directions must also appear on the container.

Summary Table of Counseling and Labeling

Area Regulation Key Requirements

Duty to Consult 16 CCR § 1707.2 Mandatory for all new prescriptions and changes in dose/strength/directions.

Consultation Content 16 CCR § 1707.2 Must include directions, storage, compliance, precautions, and side effects.

Label Format 16 CCR § 1707.5 50% of label dedicated to primary info in 12-point sans-serif font.

Label Primary Info 16 CCR § 1707.5 Patient name, drug name/strength, directions, and condition/purpose.

Translations 16 CCR § 1707.5 Must provide translated directions in supported languages upon request.